tiprankstipranks
Trending News
More News >
Advertisement
Advertisement
Vor Bio upgraded to Outperform from Neutral at Baird
PremiumThe FlyVor Bio upgraded to Outperform from Neutral at Baird
15d ago
Vor Bio, RemeGen announce Phase 3 study of telitacicept met primary endpoint
Premium
The Fly
Vor Bio, RemeGen announce Phase 3 study of telitacicept met primary endpoint
16d ago
Largest borrow rate increases among liquid names
Premium
The Fly
Largest borrow rate increases among liquid names
21d ago
Vor Bio files to sell 51M shares of common stock for holders
PremiumThe FlyVor Bio files to sell 51M shares of common stock for holders
1M ago
Vor Bio upgraded to Buy from Hold at Stifel
Premium
The Fly
Vor Bio upgraded to Buy from Hold at Stifel
1M ago
Vor Biopharma’s Strategic Moves and Telitacicept’s Potential Drive Buy Rating Amid Stock Decline
Premium
Ratings
Vor Biopharma’s Strategic Moves and Telitacicept’s Potential Drive Buy Rating Amid Stock Decline
1M ago
Vor Biopharma Announces 1-for-20 Reverse Stock Split
PremiumCompany AnnouncementsVor Biopharma Announces 1-for-20 Reverse Stock Split
1M ago
Largest borrow rate increases among liquid names
Premium
The Fly
Largest borrow rate increases among liquid names
2M ago
Vor Biopharma Focuses on Telitacicept Development Strategy
Premium
Company Announcements
Vor Biopharma Focuses on Telitacicept Development Strategy
2M ago

Trending

Name
Price
Price Change
S&P 500
Dow Jones
Nasdaq 100